Background: Depression is a heterogeneous disorder with multiple aetiological pathways and multiple therapeutic targets. This study aims to determine whether atypical depression (AD) characterized by reversed neurovegetative symptoms is associated with a more pernicious course and a different sociodemographic, lifestyle, and comorbidity profile than nonatypical depression (nonAD). Methods: Among 157,366 adults who completed the UK Biobank Mental Health Questionnaire (MHQ), N=37,434 (24%) met the DSM-5 criteria for probable lifetime major depressive disorder (MDD) based on the Composite International Diagnostic Interview Short Form. Participants reporting both hypersomnia and weight gain were classified as AD cases (N=2,305), and the others as nonAD cases (N=35,129). Logistic regression analyses were conducted to examine differences between AD and nonAD in depression features, sociodemographic and lifestyle factors, lifetime adversities, psychiatric and physical comorbidities. Results: Persons with AD experienced an earlier age of depression onset, longer, more severe and recurrent episodes, and higher help-seeking rates than nonAD persons. AD was associated with female gender, unhealthy behaviours (smoking, social isolation, low physical activity), more lifetime deprivation and adversity, higher rates of comorbid psychiatric disorders, obesity, cardiovascular disease (CVD), and metabolic syndrome. Sensitivity analyses comparing AD persons with those having typical neurovegetative symptoms (hyposomnia and weight loss) revealed similar results. Conclusions: These findings highlight the clinical and public health significance of AD as a chronic form of depression, associated with high comorbidity and lifetime adversity. Our findings have implications for predicting depression course and comorbidities, guiding research on aetiological mechanisms, planning service use and informing therapeutic approaches. 
Abstract:
Background: Depression is a heterogeneous disorder with multiple aetiological pathways and multiple therapeutic targets. This study aims to determine whether atypical depression (AD) characterized by reversed neurovegetative symptoms is associated with a more pernicious course and a different sociodemographic, lifestyle, and comorbidity profile than nonatypical depression (nonAD). Methods: Among 157,366 adults who completed the UK Biobank Mental Health Questionnaire (MHQ), N=37,434 (24%) met the DSM-5 criteria for probable lifetime major depressive disorder (MDD) based on the Composite International Diagnostic Interview Short Form. Participants reporting both hypersomnia and weight gain were classified as AD cases (N=2,305), and the others as nonAD cases (N=35,129). Logistic regression analyses were conducted to examine differences between AD and nonAD in depression features, sociodemographic and lifestyle factors, lifetime adversities, psychiatric and physical comorbidities. Results: Persons with AD experienced an earlier age of depression onset, longer, more severe and recurrent episodes, and higher help-seeking rates than nonAD persons. AD was associated with female gender, unhealthy behaviours (smoking, social isolation, low physical activity), more lifetime deprivation and adversity, higher rates of comorbid psychiatric disorders, obesity, cardiovascular disease (CVD), and metabolic syndrome. Sensitivity analyses comparing AD persons with those having typical neurovegetative symptoms (hyposomnia and weight loss) revealed similar results. Conclusions: These findings highlight the clinical and public health significance of AD as a chronic form of depression, associated with high comorbidity and lifetime adversity. Our findings have implications for predicting depression course and comorbidities, guiding research on aetiological mechanisms, planning service use and informing therapeutic approaches.
Introduction
Major depressive disorder (MDD) is a highly prevalent, burdensome, and heterogeneous mental health disorder. This heterogeneity presumably represents multiple causal pathways and consequently multiple therapeutic targets. The development of novel therapeutic agents would benefit from the identification of more homogeneous depression subtypes, which could be derived based on a triangulation of clinical phenotypes, risk factors and biology (Harald and Gordon, 2012) . One such subtype is depression with atypical features.
Atypical depression (AD) is an intriguing clinical phenomenon that has been recognised since the late 1950s and has evolved as a syndrome of varying definitions (Davidson and Thase, 2007, Lojko and Rybakowski, 2017) . The Diagnostic and Statistical
Manual of Mental Disorders 5 th edition (DSM-5) criteria for AD requires mood reactivity and at least two of the following symptoms: increased appetite or weight gain, hypersomnia, leaden paralysis and interpersonal rejection sensitivity (American Psychiatric Association, 2013) .
Whereas most clinical studies adopt the DSM criteria for AD, community studies tend to classify AD based purely on reversed neurovegetative symptoms (i.e., hypersomnia and increased appetite/weight gain) (Lee et al., 2009 , Levitan et al., 1997 , Matza et al., 2003 , for a number of reasons. First, reversed neurovegetative symptoms are easier to operationalise in epidemiological studies than other DSM criteria for atypicality. Second, several studies have questioned the evidential support for the role of mood reactivity and interpersonal rejection sensitivity in the diagnosis of atypical depression (Benazzi, 2002b, Parker and Thase, 2007) .
Third, reversed neurovegetative symptoms were found to be highly specific (90.5%), and have good positive predictive value (86.1%) for DSM-defined AD (Benazzi, 2002a) . Fourth, research comparing AD based on reversed neurovegetative symptoms with AD based on the full DSM criteria found similar associations with a range of sociodemographic characteristics and comorbidities (Benazzi, 2002a) . Lastly, AD based on reversed neurovegetative symptoms may be more strongly associated with external validating characteristics of AD (e.g., gender, bipolar disorder, family history of mania) than other atypical symptoms of depression (Angst et al., 2006) .
There is growing interest in understanding the epidemiological, neurobiological, and genetic underpinnings of AD (Lojko and Rybakowski, 2017) . Evidence from clinical and community-based studies suggest differences between AD and nonAD in sociodemographic factors, depression features, comorbidities, biomarkers, polygenic risk, and treatment response.
Atypical depression is more strongly associated with female gender (Angst et al., 2007 , Lee et al., 2009 , Matza et al., 2003 , younger age of depression onset, greater symptom severity, more depression episodes, greater functional impairment (Agosti and Stewart, 2001 , Blanco et al., 2012 , Nierenberg et al., 1998 , Stewart et al., 1993 , and more adverse life events (Matza et al., 2003 , Withers et al., 2013 . AD is also associated with higher rates of psychiatric comorbidity such as bipolar, anxiety, addictions, binge eating and psychotic disorders (Agosti and Stewart, 2001 , Angst et al., 2002 , Blanco et al., 2012 , Lee et al., 2009 , McGinn et al., 2005 , higher
Body Mass Index (BMI) (Lasserre et al., 2014) as well as polygenic risk scores for BMI and triglycerides (Milaneschi et al., 2016) , higher rates of metabolic syndrome, inflammation, and leptin dysregulation (Lamers et al., 2016a , Lamers et al., 2013 , Milaneschi et al., 2017a , and greater heritability than nonAD (Lamers et al., 2016b) . Existing evidence is limited by the use of different comparison groups across studies: non-atypical depression (i.e., depression without reversed neurovegetative symptoms) (e.g., Agosti and Stewart, 2001 , Lee et al., 2009 , Matza et al., 2003 , typical depression with both neurovegetative symptoms (i.e., hyposomnia and reduced appetite and/or weight loss) (e.g., Blanco et al., 2012 , Levitan et al., 1997 or just one neurovegetative symptom (i.e., appetite loss/weight loss) (e.g., Milaneschi et al., 2016) , or melancholic depression (e.g., Angst et al., 2007 , Lamers et al., 2016a ).
An important proportion of persons who experience common mental health disorders such as depression do not receive clinical assessment or treatment. Conclusions from clinical studies on depression subtypes suffer from poor external validity and are not powered enough to consider multiple outcomes. Community-based psychiatric epidemiology studies are needed to help characterize depression phenotypes based on lifetime self-reported symptoms. Existing evidence from studies that examined atypical depression with reversed neurovegetative is limited by small sample size (Benazzi, 2002a , Levitan et al., 1997 , Matza et al., 2003 , a focus on current or recent rather than lifetime depression episodes (Lee et al., 2009) , the use of different comparison groups, and data availability on a relatively limited number of comorbidities and correlates of atypical depression.
The UK Biobank MHQ is one of the largest mental health surveys ever conducted among middle-aged and older adults (Davis et al., 2018) . Given the diversity of mental health measures and linkages to UKB baseline assessments, this study offers the opportunity to replicate and extend evidence on the sociodemographic, clinical, lifestyle, and comorbidity profile of persons with lifetime AD characterized by reversed neurovegetative symptoms compared to those with nonAD, or those with typical neurovegetative symptoms. This foundational work could form the basis for exploring biomarker and genetic correlates of atypical depression in the UK Biobank, and could further guide intervention approaches.
Method

Subjects
The UK Biobank is a well-characterized cohort of over half a million participants aged 40 to 69 at baseline (2007) (2008) (2009) (2010) , providing the potential for a detailed examination of the interplay between genetic, biological, lifestyle, and environmental factors and the risk of physical and mental health disorders, which is further enhanced by planned follow-up assessments and linkages to routine healthcare records. A comprehensive description of the UK Biobank cohort, study design, and assessments has been published elsewhere (Sudlow et al., 2015) . An online Mental Health Questionnaire (MHQ) was developed and implemented into the UK Biobank web questionnaire platform with the aim to identify mental health disorders either based on self-reported symptoms matching psychiatric diagnostic criteria or based on other self-reported psychiatric diagnosis (Davis et al., 2018) . Participants who volunteered to take part in the study had higher socioeconomic status, healthier lifestyle and fewer health conditions than the general population (Davis et al., 2018 , Fry et al., 2017 
Measures
Data were accessed through standard UKB procedures (access number 34553, Matthew
Hotopf and collaborators) in July 2018. Case and control criteria for psychiatric disorders are presented in Supplementary Table 7 ( Davis et al., 2018) . All other variables were assessed using specific sets of questions and possible answers as detailed in Supplementary and recommended that CIDI-SF would be a useful general screening measure for depression, but not a highly accurate tool for prevalence estimates (Patten, 1997 , Sunderland et al., 2011 .
Online CIDI-SF screening for recurrent MDD had a 81.8% validation rate by the SCID interview, whereas the validation rate for single episode MDD was 87.6% (Levinson et al., 2017) . The lifetime version of the CIDI-SF asked about symptoms experienced during the worst ever depression episode. Consistent with previous studies (Benazzi, 2002a , Blanco et al., 2012 , Lee et al., 2009 , the presence of reversed neurovegetative symptoms was used to differentiate between AD and nonAD. Participants reporting both hypersomnia and weight gain were classified as AD cases (N=2,305), and the others classified as nonAD cases (N=35,129).
Diagnostic criteria based on self-report questionnaires were also evaluated for generalised anxiety disorder, post-traumatic stress disorder (PTSD), and bipolar affective disorder (i.e., wider bipolar disorder, bipolar I disorder, and bipolar II disorder), as defined in Supplementary Supplementary Table 6 ).
Participants were classified as having metabolic syndrome if they had a waist circumference ≥ 102 cm or above for males and ≥ 88 cm for females, and a combination of any two of the following: 1) hypertension defined as a) average systolic blood pressure ≥ 140 over three assessment occasions and/or b) average diastolic blood pressure ≥ 90 over three assessment occasions, and/or c) hypertension medication prescription, and/or d) a clinical diagnosis of hypertension according to participant self-report; 2) diabetes defined as a) diabetes medication prescription; b) a clinical diagnosis of diabetes according to participant self-report; and 3) hypercholesterolemia defined as a) statins medication prescription; b) a clinical diagnosis of hypercholesterolemia according to participant self-report.
Statistical Analysis
Univariate logistic regression models were conducted to examine differences between persons with AD (i.e., meeting the criteria for MDD + hypersomnia and weight gain) and persons with nonAD (i.e., meeting the criteria for MDD without hypersomnia and weight gain) in sociodemographic factors (i.e., age, gender, education, income, house ownership).
Multivariable logistic regression models were used to examine differences between nonAD and AD in lifestyle factors, lifetime adversities, depression features, and comorbidities, controlling for age and gender, and then also for socioeconomic factors. Sensitivity analyses were conducted to compare persons with AD (as defined above) and those with typical vegetative symptoms (i.e., meeting the criteria for MDD + reporting weight loss, and either waking up too early or trouble falling asleep).
Results
Tetrachoric correlations between CIDI-SF depressive symptoms among persons with lifetime probable MDD are presented in Supplementary Table 5 .
Prevalence of depression subtypes and associations with sociodemographic factors
The AD group (N=2,305) had a mean age of 59.8 years old and 75% were female, whereas the nonAD group (N=35,129) had a mean age of 62.4 years old and 68% were female.
Persons with AD had lower income, and they were less likely to own a mortgage or the outright for their home than persons with nonAD (see Table 1 ).
Depression course
The mean age of depression onset was 31.9 in the AD group and 35.5 in the nonAD group. Compared to persons with nonAD those with AD experienced more severe, recurrent, and lengthy depression episodes. For instance, 24% of persons with AD experienced a depression episode lasting over 2 years compared to 13% of persons with nonAD; 39% of persons with AD experienced a severe depression episode compared to 14% of persons with nonAD (i.e., depression was considered severe when all eight CIDI-SF symptoms were endorsed). Persons with AD were more likely to seek professional help for depression (see Table 2 ).
Lifestyle factors and lifetime adversities
Persons with atypical depression were more likely to be smokers, they reported higher rates of social isolation and loneliness, and lower rates of moderate physical activity.
Moreover, they were more likely to experience a variety of adverse events over their life course, including emotional, physical and sexual abuse during childhood and adulthood, financial difficulties and catastrophic trauma (see Table 3 ).
Psychiatric comorbidities
Persons with AD were more likely to experience a probable lifetime psychiatric disorder of GAD, bipolar I and wider bipolar disorder (but not bipolar II), and they were more likely to meet the criteria for PTSD. Also, persons with AD were more likely to self-report a lifetime psychiatric diagnosis, including schizophrenia, agoraphobia, social phobia, panic attacks, OCD, autism spectrum disorders, ADHD, substance and alcohol dependence, personality disorders, and self-harm. The odds of binge eating disorder were 4.6 higher among persons with AD compared to those with nonAD. Persons with AD had lower rates of anorexia and similar rates of bulimia as those with nonAD (see Table 4 ).
Physical comorbidities
Persons with AD had higher odds of long-standing illness, CVD, and metabolic syndrome; they scored higher on each of the components of the metabolic syndrome: diabetes Table 4 ).
Sensitivity analyses
All differences between AD and nonAD in depression features, sociodemographic and lifestyle factors, lifetime adversities, psychiatric and physical comorbidities remained statistically significant after accounting for socioeconomic status (i.e., income, house ownership, education), except for personality disorders and smoking status.
The requirement of participants in the AD group to have two specific symptoms (hypersomnia and weight gain) may have resulted in the selection of a more severe sample, since severity in this definition is defined by number of symptoms. Therefore, we conducted a set of sensitivity analyses that compared persons with AD (i.e., hypersomnia and weight gain) with those meeting the criteria for depression with typical neurovegetative symptoms (i.e., weight loss and hyposomnia: waking too early or trouble falling asleep), thereby requiring two specific symptoms in both samples. Among depressed persons with typical neurovegetative symptoms 24% had severe depression, versus 39% of AD persons. These sensitivity analyses revealed a similar pattern of findings (in terms of direction, magnitude, and statistical significance of the effect) as the main analyses using nonAD as the comparison group, except for gender differences and personality disorder differences which were no longer statistically significant (see Supplementary Tables 1-4) .
Discussion
This study ascertains AD based on reversed neurovegetative symptoms as a valid entity in a large community-based sample, and it informs on differences between AD and nonAD in terms of sociodemographic, lifestyle, and clinical characteristics, lifetime psychiatric and physical comorbidities. These findings highlight the clinical and public health significance of the AD classifier.
The previously reported prevalence of AD based on reversed neurovegetative symptoms was in the range of 11-16% (Horwath et al., 1992 , Levitan et al., 1997 . In our study about 6.5% (N=2305) of persons with MDD met the criteria for AD. Given that the UK Biobank sample is not representative for the general population (i.e., healthy volunteer effect) these results should not be interpreted as estimates of AD prevalence in the wider community, but rather as proportions within the sample. Building on prior evidence, our findings suggest that persons with AD have a younger age of depression onset (Blanco et al., 2012 , Koyuncu et al., 2015 , Matza et al., 2003 , Novick et al., 2005 , Thase, 2007 , longer (Angst et al., 2002, Posternak and Zimmerman, 2002) , more severe (Blanco et al., 2012 , Novick et al., 2005 , and recurrent episodes (Blanco et al., 2012 , Koyuncu et al., 2015 , and higher help seeking rates (Angst et al., 2006 , Lee et al., 2009 , Matza et al., 2003 compared to persons with nonAD.
Consistent with previous evidence, we found that depression with atypical features was Previously, childhood trauma, in the form of physical or sexual abuse, was associated with the reversed neurovegetative symptoms of AD (Matza et al., 2003) . Our findings add to the existing literature by showing that AD is associated with a range of emotional, physical, sexual, financial and catastrophic adversities across the lifespan.
The diversity of mental health assessments in the MHQ offered the opportunity to examine associations between AD and a wide range of lifetime psychiatric comorbidities. Our findings on psychiatric comorbidities are consistent with a large community-based study on lifetime atypical depression conducted in the United States (Blanco et al., 2012) . We found that persons with AD had higher rates of bipolar I and wider bipolar disorder than those with nonAD, but differences in bipolar II disorder were only marginally significant. An association between AD and bipolar I but not bipolar II was previously reported by Blanco et al. (2012) , but most existing evidence supports a strong association between AD and bipolar II disorder (Agosti and Stewart, 2001 , Akiskal and Benazzi, 2005 , Angst et al., 2002 , Benazzi, 2002a , Lee et al., 2009 . The failure to replicate this finding in our study may be due to the arguable definition of bipolar II disorder in the MHQ (Davis et al., 2018) (see Supplementary Table 7) .
Our findings are consistent with prior evidence suggesting higher rates of anxiety disorders (i.e., generalised anxiety, panic attacks, social phobia, agoraphobia) (Angst et al., 2002 , Blanco et al., 2012 , Horwath et al., 1992 , Koyuncu et al., 2015 , Matza et al., 2003 , Novick et al., 2005 , Sullivan et al., 1998 , OCD (Perugi et al., 1998) , psychotic disorders (Blanco et al., 2012) , binge eating (Angst et al., 2006 , Angst et al., 2002 , substance and alcohol dependence (Blanco et al., 2012) , and personality disorders (McGinn et al., 2005) among persons with AD.
Additionally, we found that persons with AD had higher rates of ADHD, autism, and selfharm, but they were not more likely than persons with nonAD to self-harm with suicide intent.
A study conducted in Hong Kong reported a trend for higher rates of suicidal ideation and suicidal attempt in AD (Lee et al., 2009 ).
The association between MDD and obesity is supported by widespread evidence, including findings from a recent UK Biobank study (Ul-Haq et al., 2014) . Emerging evidence suggests higher rates of obesity and metabolic syndrome among persons meeting the full DSM-IV criteria for atypical depression (Lasserre et al., 2014) and among those meeting only the hyperphagia and weight gain criteria (Lamers et al., 2013) . Recent evidence also suggests a genetic overlap between obesity and an AD subtype characterized by increased appetite and weight gain (Milaneschi et al., 2017b) . We found that among persons with AD characterized by reversed neurovegetative symptoms 49% were obese (BMI ≥ 30) and 36% were overweight (BMI ≥ 25), whereas among nonAD persons 22% were obese and 39% were overweight.
Biological theories propose that leptin dysregulation and inflammation underlie the association between obesity and atypical depression, whereas psychological theories suggest that the interpersonal rejection sensitivity that is characteristic to AD is accompanied by emotional dysregulation mechanisms and self-consolatory behaviours such as comfort eating (for a review see Lojko and Rybakowski, 2017) . With regard to the association between atypical depression and CVD, prior evidence is mixed, with some findings suggesting a higher CVD incidence among AD persons with reversed neurovegetative symptoms (Case et al., 2018) , whereas other reports support and association between atypical depression and cardiovascular risk factors but not CVD diagnosis (Niranjan et al., 2012) . Our findings confirm higher rates of CVD among AD persons. It should be noted that information on physical comorbidities was collected during the UK Biobank baseline assessments conducted approximately seven years before the MHQ. The relation between depression and comorbidities such as obesity, metabolic syndrome and CVD is likely multifaceted and bidirectional. Given that our study focused on lifetime depression it was not possible to determine whether physical disorders occurred before or after the atypical depression episode, hence not allowing inferences about the direction of the effect.
Finally, it is worth noting that the same pattern of results emerged when comparing persons with AD (hypersomnia and weight gain) with those reporting the opposite/typical neurovegetative symptoms (hyposomnia and weight loss), suggesting that the observed findings are not simply attributable to the selection of more severe depression cases in the AD group.
Strengths and limitations
The current study based on the UK Biobank MHQ dataset provided a unique opportunity to identify differences between typical and atypical depression in illness course, sociodemographic and lifestyle factors, adverse life events and comorbidities in a large community sample of middle aged and older adults. However, there are also a number of limitations. First, the UK Biobank is not representative for the overall population as there is a degree of 'healthy volunteer' selection bias, with higher participation rates among females, older, better educated, less deprived, and healthier participants than the general population (Fry underestimation of the prevalence of AD in our sample, given the higher depression severity among AD patients and the fact that severely depressed persons were less likely to complete the MHQ. Second, due to the cross-sectional nature of this study, our findings do not allow to determine whether life events and comorbidities occurred before, during or after the typical versus atypical depression episode. Moreover, it was not possible to determine whether participants experienced lifetime fluctuations between typical and atypical depression episodes as suggested by previous reports (Angst et al., 2007 , Levitan et al., 1997 . Third, psychiatric conditions were assessed using self-reported symptoms and self-reported diagnosis, so they represent probable, rather than definitive, clinical diagnoses (Davis et al., 2018) . CIDI-SF does not contain questions assessing appetite changes, but only weight changes. We had no specific cut-off points to quantify the weight gain or the number of hours of sleep per night during the worst depression episode. Therefore, we cannot exclude the possibility that self-reported symptoms may be subject to recall bias or may be affected by other medical conditions.
Finally, our assessments did not capture other atypical symptoms such as leaden paralysis, interpersonal rejection sensitivity or mood reactivity. Nevertheless, our findings based on a definition of atypical depression characterized by reversed neurovegetative symptoms are remarkably consistent with prior evidence from both clinical and community-based studies.
Conclusions and implications
The Note: Models are adjusted for age and gender. Catastrophic trauma is defined being attacked, mugged, robbed, exposed to violent crime, sexual assault, serious accidents, life-threatening illness, combat or war, violent death. Note: Atypical depression is defined as meeting the DSM-V criteria for MDD and reporting symptoms of hypersomnia and weight gain; depression with typical neurovegetative symptoms is defined as meeting the DSM-V criteria for MDD and reporting symptoms of hyposomnia and weight loss. Note: Models are adjusted for age and gender. Catastrophic trauma is defined being attacked, mugged, robbed, exposed to violent crime, sexual assault, serious accidents, life-threatening illness, combat or war, violent death. .07** 0.14*** 1.00 * p < 0.05; ** p < 0.01; ***p < 0.001; the correlation between sadness and interest loss could not be computed because there are no depressed persons with a score of zero on both sadness and interest loss given that the MDD criteria require the presence of at least one of the two symptoms. 
Supplementary
Income
What is the average total income 0 = <£18,000 before tax received by your household? 1 = £18,000-30,000 2 = £30,000-52,000 3 = £52,000-100,000 4 = >£100,000 UN = Do not know DA = Prefer not to answer 
House ownership
Moderate physical
In a typical week, on how many days A binary variable was generated: activity did you do 10 minutes of moderate 1 = 10 minutes of moderate physical physical activities like carrying light activities at least 3 days a week; loads, cycling at normal pace? (do not 0 = 10 minutes of moderate physical include walking) activities less than 3 days a week;
Social isolation
(1) "Including yourself, how many 1 point for living alone people are living together in your household? Include those who usually live in the house such as students living away from home during term time, partners in the armed forces or professions such as pilots"; (2) "How often do you visit friends or 1 point for friends and family visit less family or have them visit you?
than once a month (3) "Which of the following 1 point for no participation in social [leisure/social activities] do you engage activities at least weekly in once a week or more often?".
Total score 0=3
A binary variable was derived: 0 = no social isolation, if total score ≤ 1 1 = social isolation, if total score ≥ 2
Loneliness
(1) "Do you often feel lonely?" 0 = No 1 = Yes (2) "How often are you able to confide 0 = almost daily to once every few in someone close to you?" months 1 = never or almost never Elovainio, M., C. Hakulinen, et al. A binary variable was derived. "Contribution of risk factors to excess Lonely|: total score = 2 mortality in isolated and lonely Not lonely|: total score < 2 individuals: an analysis of data from the UK Biobank cohort study." The Lancet Public Health 2: e260-e266.
Childhood adverse
Includes 1 question from each domain 0 = Never true events of the Childhood Trauma 1 = Rarely true Questionnaire. 2 = Sometimes true 3 = Often Walker, E. A., et al. (1999) 
Severe depression
Meets criteria for a lifetime diagnosis A binary variable was derived: of MDD (see Depression Ever below) 1 = severe MDD and reports all 8/8 symptoms of 0 = non-severe MDD depression assessed with CIDI-SF and reports a lot of impairment.
Recurrent depression
Regarding times in your life when you Text box for number. have had feelings of depression or loss 1 = single depression episode of interest: 2 and above = recurrent depression How many periods did you have in episodes your life lasting two or more weeks where you felt like this?
Depression duration
Please think of the two-week period in 1 = less than a month your life when your feelings of 2 = between one and three months depression or loss of interest were 3 = over three months, but less than six worst. About how long did you feel months this way? 4 = over six months, but less than 12 months 5 = one to two years 6 = over two years 
Help seeking for
